|
Workshop
[Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
Speakers:
Toby Freedman, Synapsis Search Biotech Recruiting; Rachel Kindt, Rachel Kindt Consulting; Sandra Morris, MorTil Consulting; Mandana (Mondee) Baradar, UCB; Joseph Carlino, Carlino Consulting; Anne Wong, Gilead Sciences; Kamana Singh, APS Pharma Solutions; Clare Matti, Network Partners; Ann Lucchesi, LuCore Regulatory Affairs Services; April Nguyen, MMS
Organizers:
Toby Freedman, Synapsis Search Biotech Recruiting; Rachel Kindt, Rachel Kindt Consulting; Sandra Morris, MorTil Consulting; Dean Wilson, PBSS
Date:
2024-05-30
Time:
8:30-11:30 Pacific Time
Registration fee:
$0
Location:
Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2024-05-29
(it will close sooner if the seating cap is reached)
About the Topic
Time (PST) |
Topic |
Presenter(s) |
8:30-8:50 am |
PBSS, BPPM, RAPS-SF Welcome and Introduction |
Shichang Miao (PBSS) Mandana (Mondee) Baradar (BPPM) minKamana Singh (RAPS-SF) |
8:50-9:20 am |
Career Transition Opportunities: Finding and Following Your Path |
Toby Freedman, PhD, President, Synapsis Search Biotech Recruiting Rachel Kindt, PhD, Owner, Rachel Kindt Consulting |
9:20-9:40 am |
Project Management: Overview (roles, attributes, paths, lessons learned) |
Sandra Morris, PhD, Board Member, Consultant, Executive Coach, MorTil Consulting |
9:40-9:50 am |
Panelist presentation |
Mandana (Mondee) Baradar, MBA, Sr. Program Manager, UCB |
9:50-10:00 am |
Panelist presentation |
Joseph Carlino, PhD, Principal, Carlino Consulting |
10:00-10:10 am |
Panelist presentation |
Anne Wong, Associate Director, Global Program Management, Gilead Sciences |
10:10-10:30 am |
Q&A (PM) |
PM presenters and panelists |
10:30-10:40 am |
Break |
|
10:40-11:00 am |
Regulatory Affairs: Overview (roles, attributes, paths, lessons learned) |
Kamana Singh, MBA, Founder/Executive Consultant, APS Pharma Solutions |
11:00-11:10 am |
Panelist presentation |
Clare Matti, MS, Sr. Regulatory Affairs Consultant, Network Partners |
11:10-11:20 am |
Panelist presentation |
Ann Lucchesi, MS, Regulatory Affairs Professional, LuCore Regulatory Affairs Services |
11:20-11:30 am |
Panelist presentation |
April Nguyen, PharmD, RAC, MPH, Sr. Global Regulatory Affairs Manager, MMS |
11:30-11:50 am |
Q&A (Regulatory) |
Regulatory presenters and panelists |
11:50 am-12:20 pm |
Panel discussion |
All presenters and panelists |
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
|
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
|
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
|
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
|
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
|
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
|
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
|
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Submit a Text Ad
|